Dividend · Rs 1.10 · XD Jun 1, 2026
First Interim dividend of LKR 1.1/share; XD 2026-06-01; record 2026-06-01; payable 2026-06-18; FY 31st March 2026
Healthcare · Hospital/Nursing Management
Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services.
CHL shares are up 34.4% over the past year and last closed at Rs 61.00 on Sep 30, 2026.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +30.1 | -3.2 | -29.4 | +9.3 | -5.5 | +3.7 | -3.6 | +1.1 | -2.7 | +0.0 | +0.0 | +0.0 |
| 2025 | +8.8 | +0.0 | +3.0 | -2.2 | +12.0 | +2.1 | +18.9 | +8.8 | +2.2 | +50.7 | -6.6 | +1.5 |
| 2024 | +5.4 | -9.1 | +4.1 | +4.2 | -3.0 | -1.2 | +1.3 | -4.0 | +0.7 | +0.0 | -1.7 | +0.0 |
| 2023 | -2.8 | +0.8 | +0.9 | -9.8 | -3.9 | -1.8 | +8.8 | -4.0 | +0.8 | +3.2 | +0.0 | -7.7 |
| 2022 | +8.6 | -9.1 | -32.3 | +13.3 | +10.0 | -9.1 | +19.1 | -1.5 | +0.0 | +3.3 | -1.8 | +5.1 |
| 2021 | +1.0 | +0.0 | -2.9 | +2.0 | +1.2 | +0.5 | +1.9 | -0.2 | +14.3 | +4.9 | +5.5 | +12.6 |
| 2020 | +5.1 | +5.9 | +0.0 | +0.0 | +0.0 | -10.9 | +12.4 | -3.2 | +10.2 | +3.0 | +6.1 | -1.6 |
| 2019 | +5.5 | +0.1 | -2.7 | +2.5 | +8.0 | +0.4 | -5.2 | +5.1 | -9.8 | +6.6 | +0.3 | +0.0 |
| 2018 | -2.4 | +1.9 | -3.0 | +6.3 | -0.8 | -9.8 | +2.2 | +4.2 | -6.2 | -2.8 | +6.8 | -9.9 |
| 2017 | +3.0 | -2.2 | +7.8 | -5.2 | +5.6 | +5.3 | -12.5 | -1.0 | -1.8 | +5.9 | +0.0 | +0.0 |
| 2016 | -9.8 | +0.0 | +0.0 | +0.0 | +10.5 | +2.4 | -7.0 | -3.4 | +3.5 | +9.3 | +0.0 | +0.0 |
| 2015 | -5.5 | -0.9 | +4.5 | +0.0 | +0.0 | +4.4 | -0.4 | +0.6 | +4.4 | -12.2 | +0.0 | +0.0 |
| 2014 | -2.7 | +7.9 | -0.4 | -2.6 | -1.8 | -4.5 | +7.6 | -6.9 | -0.9 | +6.7 | -5.6 | +11.7 |
| 2013 | +5.4 | +7.2 | -3.8 | +1.9 | +4.0 | -0.9 | +0.1 | +1.8 | +2.8 | +0.0 | +0.0 | +0.0 |
| 2012 | +0.0 | +0.0 | +0.0 | +3.6 | -6.8 | +15.0 | -5.6 | +5.3 | +12.5 | +0.2 | +6.4 | -4.2 |
| Average | +3.6 | -0.1 | -4.5 | +1.9 | +2.3 | -0.3 | +2.5 | +0.2 | +2.0 | +5.6 | +0.8 | +0.7 |
| ASPI average | +3.1 | -2.7 | -4.7 | +2.0 | +0.2 | +0.8 | +3.1 | +2.2 | +3.2 | -0.1 | +1.0 | +3.0 |
| Median | +4.1 | +0.0 | -1.5 | +2.2 | +1.2 | +0.4 | +1.3 | -0.2 | +0.8 | +3.3 | +0.0 | +0.0 |
| % up | 64% | 46% | 42% | 67% | 54% | 53% | 60% | 47% | 60% | 71% | 45% | 36% |
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | Rs 11.0B +12.6% | Rs 9.8B +6.5% | Rs 9.2B +15.8% | Rs 7.9B +0.8% | Rs 7.8B +41.4% | Rs 5.5B -7.2% | Rs 6.0B +2.9% | Rs 5.8B +1.3% |
| Operating profit | Rs 1.6B +34.5% | Rs 1.2B +64.6% | Rs 703.9M -25.2% | Rs 941.0M -30.9% | Rs 1.4B +112.8% | Rs 639.8M -0.7% | Rs 644.6M +3.5% | Rs 622.9M -5.5% |
| Net profit | Rs 1.1B +44.9% | Rs 726.0M +60.0% | Rs 453.8M -30.4% | Rs 651.7M -41.3% | Rs 1.1B +84.8% | Rs 600.3M +28.5% | Rs 467.1M +24.1% | Rs 376.3M -22.9% |
| EPS | 5.68 -65.3% | 16.38 +41.3% | 11.59 -31.3% | 16.88 -41.8% | 29.00 +75.3% | 16.54 +38.9% | 11.91 +25.4% | 9.50 -20.0% |
Compared with the same period a year earlier.
Per-share figures are as reported, not adjusted for splits.
| # | Company | Price | Mkt cap | P/E | P/B | EPS | ROE | Div Yield |
|---|---|---|---|---|---|---|---|---|
| 1 | ASIR.N0000 | 28.10 | Rs 32.0B | 6.4 | 1.25 | 4.39 | 11.69% | 0.00% |
| 2 | LHCL.N0000 | 114.75 | Rs 25.7B | 10.8 | 1.57 | 10.66 | 14.56% | 2.61% |
| 3 | NHL.N0000 | 11.50 | Rs 16.2B | 15.3 | 2.67 | 0.75 | 16.28% | 0.00% |
| 4 | CHL.N0000 · this company | 61.00 | Rs 9.7B | 10.7 | 0.85 | 5.68 | 8.07% | 1.80% |
| 5 | SINH.N0000 | 22.10 | Rs 9.5B | 43.9 | 7.92 | 0.50 | 4.65% | 0.00% |
| 6 | AMSL.N0000 | 12.80 | Rs 6.8B | 8.0 | 0.92 | 1.61 | 11.46% | 0.00% |
| Peer median · 5 companies | - | - | 10.8 | 1.57 | - | - | 0.00% |
Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services. The Group's narrative focuses on delivering inpatient, outpatient and day-case care alongside specialised clinical services supported by surgical and diagnostic capabilities. Operations include the main Durdans hospital and an islandwide laboratory and diagnostics network, complemented by education and workforce development through the Amrak Institute of Medical Sciences and related subsidiaries. Named subsidiaries in the Group scope include Durdans Medical & Surgical Hospital (Pvt) Ltd, Amrak Institute of Medical Sciences (Pvt) Ltd and Ceygen Biotech (Pvt) Ltd. The Group operates across Sri Lanka with its head office in Colombo and has expanded services into regions including Galle and Kurunegala, maintaining standards aligned with international accreditation and pursuing digital and service expansion initiatives.
Ceylon Hospitals delivered 44.9% annual net-profit growth, but the latest quarter showed weaker operating profit. The key tension is improving earnings against softer operating momentum.
Read the full report (Aug 14, 2026) →No scored news in the last 30 days.
Dividend · Rs 1.10 · XD Jun 1, 2026
First Interim dividend of LKR 1.1/share; XD 2026-06-01; record 2026-06-01; payable 2026-06-18; FY 31st March 2026
Share split · 1:4 · XD Mar 5, 2026
Colombo bourse closed the week up 3.45% as the ASPI rose 0.54% yesterday to 23,654.30, with the market gaining about Rs. 264.8 billion in value for the week and daily turnover over Rs. 8.5 billion; top contributors included JKH, COMB, VONE, CARS and NTB.
Ceylon Hospitals (Durdans) will seek shareholder approval to subdivide voting shares from 31,762,723 to 127,050,892 and non-voting shares from 10,133,765 to 40,535,060 (1-for-4); stated capital will remain at 1,778,802,331.50 rupees and the plan is pending regulatory approval.
Ceylon Hospitals (Durdens) will propose a 4-for-1 subdivision of both ordinary voting and non-voting shares, subject to regulatory and shareholder approvals. Voting shares would rise to 127,050,892 and non-voting to 40,535,060, with stated capital unchanged at Rs. 1,778,802,331.50.
Share split · 1:4 · XD Mar 5, 2026
Split issue
The Association of Private Hospitals and Nursing Homes appointed a new Governing Council for 2025–2027, naming Raveen Wickramasinghe as President. The council includes representatives from Asiri, Nawaloka, Lanka, Ceylon and Singhe hospitals and will focus on policy advocacy, quality and capacity building.
Colombo market opened lower as the ASPI fell 0.10% to 22,788.79; major movers included Colombo Dockyard (DOCK +24.20%) and Ceylon Hospitals (CHL +25.64%), while C T Holdings, Central Finance and Richard Pieris were among the session's laggards.
Brand Finance published Sri Lanka's 100 Most Valuable Brands for 2025, ranking Bank of Ceylon top with a brand value of Rs.57,411m; Commercial Bank, Dialog and People’s Bank follow the top positions. The list covers firms across banking, telecoms, FMCG, healthcare, hospitality and other sectors.
Dividend · Rs 4.00 · XD Jun 23, 2025
First Interim dividend of LKR 4/share; XD 2025-06-23; record 2025-06-23; payable 2025-07-11; FY 31st March 2025
Healthcare news centred on public-sector capacity and control. The Government will take full ownership of Neville Fernando Hospital, with the Sri Lanka Air Force managing daily operations and Treasury funding salaries and operations. Cabinet approved 39 hospital infrastructure projects for the public investment programme, alongside NIC-linked e-health records, while four hospital construction projects were launched, including cardiology and emergency facilities.
Auto-generated from 4 sector news articles over 14 days. Not investment advice.